Envision Report

Published January 11, 2018

Global Nuclear Medicine Market – Size, Outlook, Trends and Forecasts (2018 – 2024)

Download Free Sample Report!

Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose and determine the severity of or treat a variety of diseases, including many types of cancers, heart disease, gastrointestinal, endocrine, neurological disorders and other abnormalities within the body. Nuclear medicine procedures can pinpoint molecular activity within the body; they offer the potential to identify the disease in its earliest stages as well as a patient’s immediate response to therapeutic interventions.

Global Nuclear Medicine Market Segments Size & Growth:

Global Nuclear medicine market size is projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024.Key parameters promoting the market growth include increasing incidents of cancer and cardiac ailments, expanding SPECT AND PET applications and growing public awareness for healthcare and so on. However, the Short half-life of radiopharmaceuticals, the high capital investment required for development and stringent regulatory guidelines are thereby hampering the market growth.

Global Nuclear Medicine Market Segments Share:

Global Nuclear Medicine Market is categorised into Diagnostics which comprise of PET market and SPECT market. By Therapeutics, The market is segregated into Alpha Emitters, Beta Emitters, Brachytherapy. By Applications, The market is segmented into PET and Spect Market. By Geography, North America is projected to dominate the Global Nuclear Medicine market, and the growth in the North America economies is mainly attributed because of huge profit margins and growth prospects, Global Nuclear Medicine Market Trends:

  • The utilization of myocardial perfusion imaging increased most significantly, i.e. 250 per million population (PMP) increment annually, followed by the whole-body bone scan (176 PMP) and whole-body PET scan (100 PMP) in Taiwan during the period of 2000-2012.
  • Molecular imaging using high-resolution single-photon emission computed tomography (SPECT) and positron emission tomography (PET) has advanced elegantly and has steadily gained importance in the clinical and research arenas.
  • Mallinckrodt plc, a leading global speciality pharmaceutical company, and Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets.

Global Nuclear Medicine Market Research Report:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • The primary market players, such as
  • Mallinckrodt
  • Lantheus Medical Imaging
  • Segami Corporation
  • Siemens Healthcare
  • Bracco Imaging S.P.A.

Chapter 1 Introduction

1.1 Executive Summary

1.2 Market Definition

1.3 Scope of  the Study

Chapter 2 Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Analytic Tools and Model

2.4 Economic Indicator

2.4.1 Base Year, Base Currency, Forecasting Period

2.5 Expert Validation

2.6 Study Timeline

Chapter 3 Market Analysis

3.1 Industry Value Chain Analysis

3.2 Porter’s Five Analysis

3.2.1 Bargaining Power of Buyers

3.2.2 Bargaining Power of Suppliers

3.2.3 Threats of Substitutes

3.2.4 Threats of New Entrants

3.2.5 Industry Rivalry

3.3 PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4 SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threat

3.5 Y-O-Y Analyses

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5 Market Segmentation Analysis        

Chapter 6 Market Segmentation, By  Diagnostics

     6.1 Pet Market

6.2 Spect Market

Chapter 7 Market Segmentation, By Therapeutics   

7.1  Brachytherapy

7.2 Beta Emitters

7.3 Alpha Emitters     

Chapter 8  Market Segmentation, By Application

     8.1 Pet Market

8.2 Spect Market          

Chapter 9 Market Segmentation, By Geography

9.1 North America

9.1.1 Introduction

9.1.2 United States

9.1.3 Canada

9.1.4 Mexico

9.1.5 Others

9.2 Europe

9.2.1 Introduction

9.2.2 U.K

9.2.3 Spain

9.2.4 Italy

9.2.5 France

9.2.6 Russia

9.2.7 Others

9.3 Asia-Pacific

9.3.1 Introduction

9.3.2 China

9.3.3 India

9.3.4 Japan

9.3.5 Australia & New Zealand

9.3.6 Others

9.4 South  America

9.4.1 Introduction

9.4.2 Brazil

9.4.3 Argentina

9.4.4 Others

9.5 The Middle East & Africa

9.5.1 Introduction

9.5.2 South Africa

9.5.3 Others

Chapter 10 Competitive Landscape

10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements

10.2  Market Share Analysis

10.3 Strategies Adopted By Top Companies

Chapter 11 Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

11.1. GE Healthcare

11.1.1. Company Overview

11.1.2. Financial Performance

11.1.3. Product Benchmarking

11.1.4. Strategic Initiative

11.2. Cardinal Health, Inc.

11.3. Cambridge Isotope Laboratories, Inc.

11.4. Bracco Pharma

11.5. Bracco Imaging S.P.A.

11.6. NTP Radioisotopes SOC Ltd

11.7. Siemens Healthcare

11.8. Triad Isotope

11.9. Iba Group

11.10. Lantheus Medical Imaging

11.11. Mallinckrodt

11.12. Gamma Medica Inc

11.13. Segami Corporation

11.14. Digirad Corporation

11.15. Agfa-Gevaert N.V

Chapter 12 Market Estimates and Forecast

12.1   Market Estimates and Forecast 2018-2024(USD Million)

12.1.1 Market Estimation and Forecast by Diagnostic 2018-2024 (USD Million)

12.1.2 Market Estimation and Forecast by Therapeutics 2018-2024 (USD Million)

12.1.3 Market Estimation and Forecast by Application 2018-2024 (USD Million)

12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)

Chapter 13 Market Insights

13.1 Insights of Industry Experts

13.2 Analyst Opinion (Market Understanding)

13.3 Investment Opportunities

Chapter 14 Appendix

14.1 List of Tables

14.2 List of Figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.